HUP0401438A2 - Gyógyszerszállító rendszerek - Google Patents

Gyógyszerszállító rendszerek

Info

Publication number
HUP0401438A2
HUP0401438A2 HU0401438A HUP0401438A HUP0401438A2 HU P0401438 A2 HUP0401438 A2 HU P0401438A2 HU 0401438 A HU0401438 A HU 0401438A HU P0401438 A HUP0401438 A HU P0401438A HU P0401438 A2 HUP0401438 A2 HU P0401438A2
Authority
HU
Hungary
Prior art keywords
delivery system
poly
core
drug delivery
membrane
Prior art date
Application number
HU0401438A
Other languages
English (en)
Inventor
Timo Haapakumpu
Juha Ala-Sorvari
Marko Aaltonen
Antti Keinänen
Manja Ahola
Original Assignee
Schering Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Oy filed Critical Schering Oy
Publication of HUP0401438A2 publication Critical patent/HUP0401438A2/hu
Publication of HUP0401438A3 publication Critical patent/HUP0401438A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgyát egy legalább egy magot és egy membránt tartalmazószállítórendszer képezi. A mag és a membrán elasztomer kompozícióbóláll, amely például poli(dimetilsziloxán)-t, egy 3,3,3-trifluorpropil-csoportokat a sziloxánegység Si atomjaihoz kötötten tartalmazósziloxánalapú elasztomert és/vagy poli(alkilén- oxid)-csoportokattartalmaz, amely utóbbiak a polisziloxán-egységekhez szilícium-szénkötéssel kapcsolódó, alkoxi-terminális graftok vagy blokkok formájábanvannak jelen, valamint ezen formák elegyel lehetségesek. Aszállítórendszer előnyösen egy implantátum vagy egy intrauterin,intracervikális vagy intravaginális rendszer. Ó
HU0401438A 2001-08-31 2002-08-27 Drug delivery system HUP0401438A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31597201P 2001-08-31 2001-08-31
PCT/FI2002/000692 WO2003017971A1 (en) 2001-08-31 2002-08-27 Drug delivery system

Publications (2)

Publication Number Publication Date
HUP0401438A2 true HUP0401438A2 (hu) 2004-11-29
HUP0401438A3 HUP0401438A3 (en) 2008-04-28

Family

ID=23226904

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401438A HUP0401438A3 (en) 2001-08-31 2002-08-27 Drug delivery system

Country Status (14)

Country Link
US (1) US20040247674A1 (hu)
EP (1) EP1427390A1 (hu)
JP (1) JP2005503389A (hu)
KR (1) KR20040036928A (hu)
CN (1) CN1289064C (hu)
AR (1) AR036310A1 (hu)
AU (1) AU2002313517B2 (hu)
CA (1) CA2457979A1 (hu)
HU (1) HUP0401438A3 (hu)
NO (1) NO20041315L (hu)
PE (1) PE20030316A1 (hu)
PL (1) PL367961A1 (hu)
RU (1) RU2302883C2 (hu)
WO (1) WO2003017971A1 (hu)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
US20040181943A1 (en) * 2003-03-18 2004-09-23 Michael Kwiecien Shaving systems
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
CA2533013C (en) * 2003-07-17 2011-07-26 Banner Pharmacaps, Inc. Controlled release preparations
ES2561463T3 (es) * 2003-08-21 2016-02-26 Addbio Ab Dispositivo de implante recubierto con bisfosfonato y método para el mismo
AU2005258225A1 (en) * 2004-06-22 2006-01-05 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
DE602004008912T3 (de) 2004-07-13 2012-09-13 Bayer Schering Pharma Oy Retardiertes Freigabesystem mit kontrollierter Initialabgabe
US7494665B1 (en) 2004-07-30 2009-02-24 Advanced Cardiovascular Systems, Inc. Polymers containing siloxane monomers
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
BRPI0709344A2 (pt) * 2006-03-20 2011-07-12 Duramed Pharmaceuticals Inc anel intravaginal comprimido flexìvel, seu uso e processo de preparação, método de fornecer um agente ativo, kit terapêutico e produto
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
US8741329B2 (en) 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
EP2057972A1 (en) * 2007-11-07 2009-05-13 N.V. Organon Intrauterine deposit
ES2365552T3 (es) * 2007-11-22 2011-10-06 Bayer Oy Sistema de administración vaginal.
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
DE102008006416A1 (de) * 2008-01-28 2009-07-30 Mayer, Thomas, Dr. med. Clindamycin zur Verwendung bei der Behandlung oder Vorbeugung der bakteriellen Vaginosis
CA2713943C (en) * 2008-02-04 2018-10-23 Teva Women's Health, Inc. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
ES2424984T5 (es) 2008-09-17 2017-02-16 Bayer Oy Insertador
US11992431B2 (en) 2008-09-17 2024-05-28 Bayer Oy Inserter
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
TR201815588T4 (tr) * 2009-01-29 2018-11-21 Fondazione Irccs Istituto Naz Dei Tumori Serviks kanserinin lokal - bölgesel tedavisinde ilaçların salınımı için intraservikal cihaz.
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
FI122579B (fi) 2010-10-29 2012-03-30 Bayer Oy Insertteri
CN102525722A (zh) * 2010-12-30 2012-07-04 辽宁爱母医疗科技有限公司 具有记忆效应的智能型复方孕二烯酮阴道环制剂及其应用
EP2476409A1 (en) * 2011-01-14 2012-07-18 Université Catholique De Louvain Implant comprising a core and a tube encasing the core
DE202012012761U1 (de) * 2011-04-07 2013-10-29 Arstat, Inc. Mit Arzneimittel versehene intravaginale Vorrichtung und pharmazeutische Zusammensetzung zur Behandlung von Menstruationsschmerzen und übermäßigem Menstruationsblutverlust
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
EP2607451B8 (de) 2011-12-20 2019-03-27 Merck Patent GmbH Flüssigkristallines Medium
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
AU2014214538B2 (en) 2013-02-06 2018-11-15 Mark SILLENDER Embryo transfer catheter and method
AU2014214537B2 (en) * 2013-02-06 2019-01-03 Mark SILLENDER Therapeutic substance transfer catheter and method
SE539540C2 (sv) * 2013-09-12 2017-10-10 Qpharma Ab Ett läkemedelsavgivningssystem för en eller flera aktiva beståndsdelar
US9963556B2 (en) * 2013-09-18 2018-05-08 Senseonics, Incorporated Critical point drying of hydrogels in analyte sensors
TN2016000134A1 (en) * 2013-10-18 2017-10-06 Bayer Oy Intrauterine delivery system.
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10772842B2 (en) * 2015-01-09 2020-09-15 Patheon Softgels Inc. Abuse-deterrent opioids
CN106456377A (zh) * 2014-05-30 2017-02-22 纺织品技术股份有限公司 药物递送系统以及相关使用方法
HUE046267T2 (hu) 2015-01-21 2020-02-28 Bayer Oy Nem szteroid gyulladáscsökkentõ (NSAID) és progesztogén vegyületet tartalmazó gyógyszerbeviteli rendszer és elõállítási eljárások
EP3294300A1 (en) 2015-05-13 2018-03-21 Bayer Oy A long acting drug delivery device and its use in contraception
CN105056376A (zh) * 2015-08-21 2015-11-18 崔尚品 一种治疗宫颈炎和宫颈hpv感染的医疗器械
WO2019094625A1 (en) * 2017-11-09 2019-05-16 Nexien Biopharma, Inc. Methods and compositions for parenteral administration of cannabidiol in the treatment of convulsive disorders
CN110917478B (zh) * 2019-12-10 2020-11-24 河南省肿瘤医院 一种宫颈hpv感染用药物缓释器
US11338119B2 (en) * 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11344526B2 (en) * 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) * 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
WO2022029780A1 (en) * 2020-08-06 2022-02-10 Bless Medical Ltd. Intrauterine device for controlled drug release
US20230047191A1 (en) * 2021-08-05 2023-02-16 Celanese Eva Performance Polymers Llc Implantable Medical Device for the Delivery of Bisphosphonate

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
ES2054784T3 (es) * 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
US5443461A (en) * 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
DE69833375D1 (de) * 1997-06-04 2006-04-13 Debio Rech Pharma Sa Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females

Also Published As

Publication number Publication date
EP1427390A1 (en) 2004-06-16
AU2002313517B2 (en) 2007-09-06
PE20030316A1 (es) 2003-04-03
RU2302883C2 (ru) 2007-07-20
US20040247674A1 (en) 2004-12-09
JP2005503389A (ja) 2005-02-03
AR036310A1 (es) 2004-08-25
RU2004109575A (ru) 2005-08-20
CN1549703A (zh) 2004-11-24
PL367961A1 (en) 2005-03-07
HUP0401438A3 (en) 2008-04-28
WO2003017971A1 (en) 2003-03-06
CA2457979A1 (en) 2003-03-06
CN1289064C (zh) 2006-12-13
KR20040036928A (ko) 2004-05-03
NO20041315L (no) 2004-03-30

Similar Documents

Publication Publication Date Title
HUP0401438A2 (hu) Gyógyszerszállító rendszerek
HUP0204015A2 (en) Devices for the delivery of drugs having antiprogestinic properties
HUP0104037A2 (hu) Elsősorban progesztineknél és ösztrogéneknél alkalmazható hordozórendszer
WO2004064912A8 (en) An otorhinological delivery device
SE9604793L (sv) Nya Kristallmodifikationer
AU7573396A (en) Intraoral administration device and system
MA28182A1 (fr) Analogues d'oligonucleotides de classe c presentant des proprietes immunostimulatrices accrues
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
HUP0001916A2 (hu) Töltött korpuszú cukorka
ATE131029T1 (de) Lagerstabile, permanent wasserbenetzbare vulkanisate ergebende polysiloxanmasse.
HUP0102600A2 (hu) Gyógyszerek permeációs sebességét szabályozó membrán vagy mátrix
SE9702435D0 (sv) Dental impression silicone composition
MXPA03009772A (es) Metodos y composiciones para tratar lesiones orales y del esofago.
HUP0104756A2 (hu) Poliol/olaj szuszpenziók a fehérjék folyamatos kibocsátásához
DE69940635D1 (de) Copolymer-zusammensetzungen zur oralen verabreichung
BR9714465A (pt) Composição, utilização de uma associação e utilização de um silicone polioxialquilenado
HUP0104380A2 (hu) Gyógyszerhatóanyag áthatolását szabályozó membrán vagy mátrix
HUP0202666A2 (hu) Elsősorban androgéneknél alkalmazható hordozórendszer
Mazaheri et al. Bond strength of composite-resin and resin-modified glass ionomer to bleached enamel: delay bonding versus an antioxidant agent
ES2094907T3 (es) Secuencias de adn que codifican para caracteristicas de virulencia de -s(streptococcus suis) y partes del mismo, polipeptidos y anticuerpos derivados de este y su uso para la diagnosis y la proteccion contra la infeccion por -s(s. suis) en mamiferos, incluyendo el ser humano.
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
DK0613499T3 (da) Humame IT-4-mutantproteiner
DE60231131D1 (de) Vakzine und verwendung davon zur behandlung amyotrophischer lateralsklerose
ATE234835T1 (de) Trovafloxacin enhaltende suspensionen zur oralen anwendung
AU773282C (en) Silicone elastomer system having biocide properties useful in particular for making impressions in dentistry

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees